Clinical Trials Logo

Clinical Trial Summary

Although the circumstances of onset and management of exertional heatstroke have been identified for several years, its pathophysiology remains imperfectly understood. Exertional heatstroke is the result of both extrinsic (i.e. environmental) and intrinsic (i.e. individual) contributing factors. Extrinsic factors are well known (high ambient temperature and hygrometry, poorly "breathable" clothing, intense and prolonged physical effort) but some of them may be observed in milder conditions. In the French Armed Forces, 25% of the exertional heatstrokes that have been reported between 2005 and 2011 occurred below 17°C. Intrinsic factors, on the other hand, are numerous and less consensual, partly because of the imperfect knowledge of exertional heatstroke physiopathology. Potential factors include a thermoregulatory defect (inability to maintain a temperature plateau during an effort) and several genetic mutations may also contribute to explain a propensity to present an exertional heatstroke. While exertional heatstroke is clearly not a monogenic pathology, the association of several polymorphisms could contribute to this vulnerability. Among the genes that have been explored, mutations in ryanodine receptor type 1 (RyR 1), calsequestrin-1 or angiotensin-1 converting enzyme (ACE) appear to be potential candidates. However, it is very likely that other polymorphisms may be involved, such as: genes involved in sports performance and exercise rhabdomyolysis, in the inflammatory cascade, permeability of the digestive epithelial barrier, adenosine receptors and susceptibility to anxiety. Finally, motivation is a mixed factor often claimed to be involved in exertional heatstroke but has never been quantified and needs to be objectified. To date, none of these hypotheses has been clearly assessed by comparing patients who experienced exertional heatstroke to healthy subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04593316
Study type Observational
Source Direction Centrale du Service de Santé des Armées
Contact Arnaud-Xavier JOUVION, MD
Phone 491617679
Email arnaud-xavier.jouvion@intradef.gouv.fr
Status Recruiting
Phase
Start date November 2, 2020
Completion date November 2024

See also
  Status Clinical Trial Phase
Completed NCT02513095 - Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS) Phase 2
Completed NCT03513315 - Heat Emergency Awareness and Treatment (HEAT) N/A
Recruiting NCT05155358 - Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
Recruiting NCT05847465 - Study of Thermoregulation in Exercise Heat Stroke in the Military Environment
Recruiting NCT05921695 - The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke N/A
Recruiting NCT05921682 - Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke
Recruiting NCT05923931 - Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke N/A
Completed NCT01290159 - The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat N/A
Recruiting NCT06192069 - Heat Strain Prevention in Elderly Agricultural Workers N/A